Internal Medicine · Houston, TX
NPI
1578717658
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1504 Taub Loop
Houston, TX, 77030
Phone (713) 873-8890
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,531
55 services
Medicare patients, 2024
29
Average age 68
Drug cost, 2024
$1.5M
1,583 prescriptions
Company payments, 2025
$86.99
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stacey R Rose was code 99214 (office e&m - established), 23 times for 13 patients. In total Stacey R Rose billed 55 services in 10 codes, and Medicare paid $4,531.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 23 | 13 | $100.77 | $2,318 |
By year: 2022 $5,195 for 63 services; 2023 $3,880 for 47 services; 2024 $4,531 for 55 services.
Medicare prescription drug claims, 2024
In 2024, the drug Stacey R Rose prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 95 prescriptions and refills. In total Stacey R Rose wrote 1,583 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 95 | 99 | 14 | $400K |
| Atorvastatin Calcium Generic | 72 | 128 | 15 | $412 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 70 | 78 | 11 | $2,355 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 61 | 69 | Under 11 | $226K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 56 | 76 | 14 | $368 |
| Doxycycline Hyclate Generic | 45 | 61 | Under 11 | $1,737 |
| Gabapentin Generic | 44 | 66 | Under 11 | $519 |
| Valacyclovir Valacyclovir Hcl | 41 | 55 | Under 11 | $2,429 |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 40 | 40 | Under 11 | $140K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 38 | 38 | Under 11 | $147K |
| Darunavir Generic | 34 | 34 | Under 11 | $40K |
| Lisinopril Generic | 32 | 54 | Under 11 | $115 |
| Ritonavir Generic | 31 | 47 | Under 11 | $2,583 |
| Amlodipine Besylate Generic | 29 | 59 | Under 11 | $217 |
| Prezcobix Darunavir/Cobicistat | 28 | 28 | Under 11 | $70K |
Brand drugs: 503 claims; generic drugs: 1,080 claims; opioid claims: 26.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stacey R Rose $86.99 ($86.99 in general payments such as food, travel and fees) from 1 company. The largest payer was Astellas Pharma US Inc with $86.99.
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc 4503.T | 1 | $86.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.